These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28463639)

  • 1. Long-term Evaluation of Type 2 Thyroplasty with Titanium Bridges for Adductor Spasmodic Dysphonia.
    Sanuki T; Yumoto E
    Otolaryngol Head Neck Surg; 2017 Jul; 157(1):80-84. PubMed ID: 28463639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term voice handicap index after type II thyroplasty using titanium bridges for adductor spasmodic dysphonia.
    Sanuki T; Yumoto E; Kodama N; Minoda R; Kumai Y
    Auris Nasus Larynx; 2014 Jun; 41(3):285-9. PubMed ID: 24369905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of type II thyroplasty for adductor spasmodic dysphonia: analysis of revision and unsatisfactory cases.
    Sanuki T; Isshiki N
    Acta Otolaryngol; 2009 Nov; 129(11):1287-93. PubMed ID: 19863326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of type II thyroplasty on adductor spasmodic dysphonia.
    Sanuki T; Yumoto E; Minoda R; Kodama N
    Otolaryngol Head Neck Surg; 2010 Apr; 142(4):540-6. PubMed ID: 20304275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durability of Titanium Implants Following Type II Thyroplasty for Adductor Type Spasmodic Dysphonia.
    Toya Y; Hiroshiba S
    Laryngoscope; 2023 Nov; 133(11):3028-3033. PubMed ID: 37070643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medialization thyroplasty: vocal outcome of silicone and titanium implant.
    van Ardenne N; Vanderwegen J; Van Nuffelen G; De Bodt M; Van de Heyning P
    Eur Arch Otorhinolaryngol; 2011 Jan; 268(1):101-7. PubMed ID: 20617328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voice tuning with new instruments for type II thyroplasty in the treatment of adductor spasmodic dysphonia.
    Sanuki T; Yumoto E; Toya Y; Kumai Y
    Auris Nasus Larynx; 2016 Oct; 43(5):537-40. PubMed ID: 26811303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Botulinum Toxin Injections and Type 2 Thyroplasty for Adductor Spasmodic Dysphonia.
    Sanuki T; Takemoto N
    Laryngoscope; 2023 Dec; 133(12):3443-3448. PubMed ID: 37278482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall evaluation of effectiveness of type II thyroplasty for adductor spasmodic dysphonia.
    Sanuki T; Isshiki N
    Laryngoscope; 2007 Dec; 117(12):2255-9. PubMed ID: 17921901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective.
    Schuering JHC; Heijnen BJ; Sjögren EV; Langeveld APM
    Laryngoscope; 2020 Mar; 130(3):741-746. PubMed ID: 31169922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Comparison of Thyroarytenoid Muscle Myectomy and Type II Thyroplasty for Spasmodic Dysphonia.
    Nomoto M; Tokashiki R; Hiramatsu H; Konomi U; Motohashi R; Sakurai E; Toyomura F; Ueda Y; Inoue S; Tsukahara K; Suzuki M
    J Voice; 2015 Jul; 29(4):501-6. PubMed ID: 25737474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic laser thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia: a pilot study on long-term outcome on voice quality.
    Tsuji DH; Takahashi MT; Imamura R; Hachiya A; Sennes LU
    J Voice; 2012 Sep; 26(5):666.e7-12. PubMed ID: 21940146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative complications and safety of type II thyroplasty (TPII) for adductor spasmodic dysphonia.
    Mizoguchi K; Hatakeyama H; Yanagida S; Nishizawa N; Oridate N; Fukuda S; Homma A
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2215-2223. PubMed ID: 28229294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Operative Procedure of Anterior Commissure for Type II Thyroplasty.
    Matsushima K; Isshiki N; Tanabe M; Yoshizaki N; Otsu K; Fukuo A; Matsuura K; Watanabe Y; Sato K
    J Voice; 2018 May; 32(3):374-380. PubMed ID: 28687381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Voice Outcomes of Early Thyroplasty for Unilateral Vocal Fold Paralysis Following Aortic Arch Surgery.
    Kwak PE; Tritter AG; Donovan DT; Ongkasuwan J
    Ann Otol Rhinol Laryngol; 2016 Jul; 125(7):559-63. PubMed ID: 26969453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Botulinum Toxin and Surgery among Spasmodic Dysphonia Patients.
    van Esch BF; Wegner I; Stegeman I; Grolman W
    Otolaryngol Head Neck Surg; 2017 Feb; 156(2):238-254. PubMed ID: 27803079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral Vocal Fold Medialization: A Treatment for Abductor Spasmodic Dysphonia.
    Dewan K; Berke GS
    J Voice; 2019 Jan; 33(1):45-48. PubMed ID: 29132808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
    Simpson CB; Lee CT; Hatcher JL; Michalek J
    Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 thyroplasty for spasmodic dysphonia: fixation using a titanium bridge.
    Isshiki N; Yamamoto I; Fukagai S
    Acta Otolaryngol; 2004 Apr; 124(3):309-12. PubMed ID: 15141760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results after external vocal fold medialization thyroplasty with titanium vocal fold medialization implant (TVFMI).
    Schneider-Stickler B; Gaechter J; Bigenzahn W
    Eur Arch Otorhinolaryngol; 2013 May; 270(5):1689-94. PubMed ID: 23443647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.